Notable Labs, Ltd.
NTBLDelisted Mar 5, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001603207
Notable Labs, Ltd. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on May 10, 2024; 16 institutions reported holding it in 13F filings for Q3 2024, worth $197.6K in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Notable Labs, Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
NTBL is no longer listed, so this page shows Q3 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 16
- −1 vs. Q2 2024
- Shares held
- 460.6K
- +30.8K (+7.2%) vs. Q2 2024
- Total value
- $197.6K
- −$72.7K (−26.9%) vs. Q2 2024
- New holders
- 2
- 4 more added
- Sold out
- 3
- 3 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTBL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 16 | $197.6K |
| Q2 2024 | 17 | $270.3K |
| Q1 2024 | 14 | $611.8K |
| Q4 2023 | 12 | $550.4K |
| Q3 2023 | 22 | $237.1K |
| Q2 2023 | 17 | $171.8K |
| Q1 2023 | 18 | $137.3K |
| Q4 2022 | 28 | $295.1K |
| Q3 2022 | 26 | $517.6K |
| Q2 2022 | 30 | $11.1M |
| Q1 2022 | 26 | $10.8M |
| Q4 2021 | 26 | $15.2M |
| Q3 2021 | 28 | $10.2M |
| Q2 2021 | 23 | $9.16M |
| Q1 2021 | 25 | $5.39M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Notable Labs, Ltd.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Industry Ventures, L.L.C. | 204,424 | $87.9K | 0.20% | 00.0% | Unchanged |
| Founders Fund V Management, LLC | 117,924 | $50.7K | 8.87% | 00.0% | Unchanged |
| UBS Group AG | 36,002 | $15.5K | 0.00% | +31,260+659.2% | Added |
| Oppenheimer & Co Inc | 30,000 | $12.9K | 0.00% | +10,000+50.0% | Added |
| Mariner, LLC | 22,003 | $9.46K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,539 | $8.40K | 0.00% | −10,081−34.0% | Reduced |
| Two Sigma Securities, LLC | 15,274 | $6.57K | 0.00% | +15,274 | New |
| FNY Investment Advisers, LLC | 10,000 | $4.00K | 0.00% | +10,000 | New |
| BNP Paribas Arbitrage, SA | 2,199 | $946 | 0.00% | +1,100+100.1% | Added |
| Group One Trading, L.P. | 1,272 | $547 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 800 | $344 | 0.00% | +300+60.0% | Added |
| Tower Research Capital LLC (TRC) | 417 | $180 | 0.00% | −10−2.3% | Reduced |
| Advisor Group Holdings, Inc. | 229 | $98 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 115 | $49 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 44 | $18 | 0.00% | −13−22.8% | Reduced |
| Harel Insurance Investments & Financial Services Ltd. | 314 | $0 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,946−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |